These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2981718)

  • 21. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
    Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
    Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of vasoactive intestinal peptide with human blood mononuclear cells.
    Guerrero JM; Prieto JC; Elorza FL; Ramirez R; Goberna R
    Mol Cell Endocrinol; 1981 Feb; 21(2):151-60. PubMed ID: 6260561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J
    Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
    Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
    Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Functional and specific vasoactive intestinal peptide receptors in enterocytes isolated from fetal or adult rats].
    Chastre E; Gespach C; Rosselin G; Broer Y
    C R Acad Sci III; 1985; 300(9):399-404. PubMed ID: 2986802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.
    Schwartz CJ; Kimberg DV; Sheerin HE; Field M; Said SI
    J Clin Invest; 1974 Sep; 54(3):536-44. PubMed ID: 4369434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone-specific combinations of isoforms of adenylyl cyclase and phosphodiesterase in the rat liver.
    Yamatani K; Saito K; Takahashi K; Ohnuma H; Manaka H; Sasaki H
    Regul Pept; 2001 May; 99(1):45-52. PubMed ID: 11257314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactive intestinal peptide receptor activity and specificity during enterocyte-like differentiation and retrodifferentiation of the human colonic cancerous subclone HT29-18.
    Chastre E; Emami S; Rosselin G; Gespach C
    FEBS Lett; 1985 Sep; 188(2):197-204. PubMed ID: 2993022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig.
    Dupont C; Broyart JP; Broer Y; Chenut B; Laburthe M; Rosselin G
    J Clin Invest; 1981 Mar; 67(3):742-52. PubMed ID: 6259209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity.
    Gespach C; Emami S; Rosselin G
    Biochem Biophys Res Commun; 1984 Apr; 120(2):641-9. PubMed ID: 6329177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.
    Besson J; Malassiné A; Ferré F
    Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis.
    Chastre E; Bawab W; Faure C; Emami S; Muller F; Boué A; Gespach C
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G561-9. PubMed ID: 2552825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.
    Rosselin G
    Peptides; 1986; 7 Suppl 1():89-100. PubMed ID: 3018707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
    Gespach C; Hui Bon Hoa D; Rosselin G
    Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
    Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J
    Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.